Assay ID | Title | Year | Journal | Article |
AID1604886 | Activation of LasR in Pseudomonas aeruginosa PAO-JP2 harboring plasI-LVAgfp incubated for 6 hrs by fluorescence method | 2020 | Bioorganic & medicinal chemistry, 02-01, Volume: 28, Issue:3
| Impact of the structure-activity relationship of AHL analogues on quorum sensing in Gram-negative bacteria. |
AID152943 | Inhibition of human peripheral blood mononuclear cell (PBMC)donor C proliferation | 2003 | Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
| Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators. |
AID615222 | Antagonist activity at Agrobacterium tumefaciens TraR receptor in presence of 100 nM 3-oxo-C8-HSL | 2010 | Journal of medicinal chemistry, Nov-11, Volume: 53, Issue:21
| Medicinal chemistry as a conduit for the modulation of quorum sensing. |
AID395857 | Agonist activity at Escherichia coli DH5alpha LasR receptor by beta-galctosidase reporter gene assay | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluation of a focused library of N-aryl L-homoserine lactones reveals a new set of potent quorum sensing modulators. |
AID152953 | Inhibition of LPS-induced human TNF-alpha secretion; ND means not determined. | 2003 | Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
| Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators. |
AID615272 | Antagonist activity at Pseudomonas aeruginosa LasR receptor expressed in Escherichia coli in presence of 7.5 nM natural auto-inducer 3-oxo-C12-HSL | 2010 | Journal of medicinal chemistry, Nov-11, Volume: 53, Issue:21
| Medicinal chemistry as a conduit for the modulation of quorum sensing. |
AID1604888 | Activation of LasR in Escherichia coli JLD271 harboring pSC11/pJN105L using CPRG as substrate incubated for 4 hrs by Miller assay method | 2020 | Bioorganic & medicinal chemistry, 02-01, Volume: 28, Issue:3
| Impact of the structure-activity relationship of AHL analogues on quorum sensing in Gram-negative bacteria. |
AID1604885 | Inhibition of LasR in Pseudomonas aeruginosa PAO-JP2 harboring plasI-LVAgfp incubated for 6 hrs by fluorescence method | 2020 | Bioorganic & medicinal chemistry, 02-01, Volume: 28, Issue:3
| Impact of the structure-activity relationship of AHL analogues on quorum sensing in Gram-negative bacteria. |
AID318820 | Inhibition of Pseudomonas aeruginosa LasR | 2008 | Bioorganic & medicinal chemistry letters, May-15, Volume: 18, Issue:10
| Synthetic ligands that activate and inhibit a quorum-sensing regulator in Pseudomonas aeruginosa. |
AID395858 | Agonist activity at Vibrio fischeri ES114 LuxR receptor by luciferase reporter gene assay | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluation of a focused library of N-aryl L-homoserine lactones reveals a new set of potent quorum sensing modulators. |
AID142576 | Inhibition of murine splenocyte proliferation | 2003 | Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
| Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators. |
AID152941 | Inhibition of human peripheral blood mononuclear cell (PBMC)donor A proliferation | 2003 | Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
| Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators. |
AID318815 | Agonist activity at Pseudomonas aeruginosa QscR expressed in Escherichia coli assessed as production of beta-galactosidase | 2008 | Bioorganic & medicinal chemistry letters, May-15, Volume: 18, Issue:10
| Synthetic ligands that activate and inhibit a quorum-sensing regulator in Pseudomonas aeruginosa. |
AID615273 | Agonist activity at Pseudomonas aeruginosa LasR cognate receptor expressed in Escherichia coli harboring pKDT17 assessed as activation of lasB expression by LacZ reporter gene assay | 2010 | Journal of medicinal chemistry, Nov-11, Volume: 53, Issue:21
| Medicinal chemistry as a conduit for the modulation of quorum sensing. |
AID615275 | Induction of quorum sensing regulated bioluminescence in Vibrio fischeri by luminescence assay relative to natural autoinducer | 2010 | Journal of medicinal chemistry, Nov-11, Volume: 53, Issue:21
| Medicinal chemistry as a conduit for the modulation of quorum sensing. |
AID152955 | Inhibition of human peripheral blood mononuclear cell (PBMC)donor B proliferation; ND means not determined. | 2003 | Journal of medicinal chemistry, Jan-02, Volume: 46, Issue:1
| Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators. |
AID615221 | Antagonist activity at Vibrio fischeri luxR receptor in presence of 5 uM 3-oxo-C6-HSL | 2010 | Journal of medicinal chemistry, Nov-11, Volume: 53, Issue:21
| Medicinal chemistry as a conduit for the modulation of quorum sensing. |
AID318814 | Agonist activity at Pseudomonas aeruginosa QscR expressed in Escherichia coli assessed as production of beta-galactosidase at 5 uM relative to dodecanoyl homoserine lactone | 2008 | Bioorganic & medicinal chemistry letters, May-15, Volume: 18, Issue:10
| Synthetic ligands that activate and inhibit a quorum-sensing regulator in Pseudomonas aeruginosa. |
AID395856 | Agonist activity at Agrobacterium tumefaciens WCF47 TraR receptor by beta-galctosidase reporter gene assay | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluation of a focused library of N-aryl L-homoserine lactones reveals a new set of potent quorum sensing modulators. |
AID1604887 | Inhibition of LasR in Escherichia coli JLD271 harboring pSC11/pJN105L using CPRG as substrate incubated for 4 hrs by Miller assay method | 2020 | Bioorganic & medicinal chemistry, 02-01, Volume: 28, Issue:3
| Impact of the structure-activity relationship of AHL analogues on quorum sensing in Gram-negative bacteria. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |